Origin and differentiation of a new class of serotonin-expressing enteroendocrine cells
Andrew Leiter, MD, PhD
Finished Projects
Overcoming Resistance to mTOR Inhibition in pancreatic NETs
Eric Nakakura, MD, PhD
Personalized Immunotherapy for Atypical Pulmonary Carcinoids
Kevin McHugh, PhD
Phase 1 study of SurVaxM ™ in survivin-positive NETs
Renuka Iyer, MD
Preclinical Toxicity and Therapy Study of 225Ac-crown-TATE
Paul Schaffer, PhD
Profiling of secreted immune mediators in NETs
Matthew H. Kulke, MD
Proteogenomic analysis of pancreatic NETs
Sharon Gorski, PhD
Radiosensitizing NETs: a two-pronged approach using ERa and Pin1 inhibition
Xavier M. Keutgen, MD
Role of CCL2 and IL-8 in Pituitary Neuroendocrine Tumor Microenvironment
Pedro Marques, MD, PhD
Simultaneous Auger-e- and β--Particle therapy of metastasized NET using 161Tb-DOTATOC
Roger Schibli, PhD